Stem Cells & Skin Care
The science behind the growth factors and human stem-cell-conditioned media that form the basis for many new cosmeceuticals.

Google the words “human stem cells skin care” and you will see more than 3 million search results. But when it comes to topical skincare products, the discussion of stem cells is really about growth factors, cytokines and chemokines. Some are grown in the laboratory and others are found in stem-cell-conditioned media.

Cytokines and chemokines are signaling proteins, released by cells, that serve...

Articles

Stem Cells & Skin Care

Google the words “human stem cells skin care” and you will see more than 3 million...

Expanding Your Career

If you’re like most people, you harbor a secret goal. Perhaps you think to yourself, “...

Contoured Curves

Noninvasive body contouring continues to generate enormous interest among patients,...

Laser Focus

Jill Waibel, MD’s interest in science was piqued at a young age. Both of her...

Products

Eight-Hour Hydration

G.M. Collin Hydramucine Optimal Serum moisturizes dehydrated skin for eight...

Glacial Cleanser

Valmont’s Eau Micellaire Précieuse from the Elixir des Glaciers line uses...

Neck Rejuvenation

Marini Juveneck from Jan Marini Skin Research is specially formulated to...

Multi-Tech Aesthetics

The V30 multi-technology platform by Viora allows you to address multiple...

Sebacia Microparticles Successfully Treat Acne

In two independent European clinical studies, Sebacia gold microparticles were found to effectively reduce the appearance of inflammatory acne lesions. The gold and silica microparticles are placed in a suspension designed to penetrate the sebaceous follicles. When activated by the light of a hair removal laser, they create a focused photo-thermal effect that reduces the activity level of the sebaceous gland and follicle.

A total of 97 subjects with acne vulgaris on their arms were treated. The studies were designed as 1:1 randomization with crossover control groups—the control arm in the first study received over-the-counter face wash, and in the second study the control was the suspension without Sebacia microparticles and laser treatment.

Results showed a significant decrease in inflammatory lesions and IGA scores in the treated arms versus the control arms at 12 weeks in both studies. Inflammatory lesion count reduction was approximately 60% at six months. Treatment was well tolerated, and side effects were limited to transient mild erythema and mild edema.

“Sebacia treatment provided a significant and sustained reduction in acne for the patients in our clinical trial,” said Witold Owczarek, MD,...

Galderma Restylane Silk for Lip and Perioral Treatments

Global healthcare company Galderma has announced that Restylane Silk, the first and only dermal filler FDA-approved for lip enhancement and the treatment of perioral lines and wrinkles, is now available in the U.S.

In a clinical study involving 221 patients, researchers observed that 77% of patients treated with Restylane Silk showed an improvement in lip fullness eight weeks post-treatment, and 59% of treated patients maintained lip fullness for six months. In the same study, 98% of patients reported a visible improvement in the fullness of their lips 14 days after injection, and 76% reported that they still had lip improvement six months following injection. The most common side effects were swelling, tenderness, bruising, pain and redness. The majority of these side effects were mild and decreased in severity within two to seven days.

“Restylane Silk is an exciting advancement on the safe, effective and proven Restylane technology that was engineered specifically to treat the sensitive and delicate area in the lips and around the mouth,” said Kenneth Beer, MD, director of Kenneth Beer MD PA Cosmetic, Surgical and General Dermatology in Palm Beach, Florida, and an investigator in the Restylane Silk Phase 3...

ALPHAEON Appoints Presidents of the Americas and Asia Pacific

Jeff Castillo, MBA, has joined lifestyle healthcare company ALPHAEON as President of the Americas. Castillo was previously divisional vice president at Abbott Medical Optics (AMO) where he focused on customer needs and market dynamics. Prior to AMO, Castillo spent 22 years at Johnson & Johnson, where he held a variety of senior commercial positions based in the U.S. and Latin America.

Kuntal Joshi, MBA, has joined ALPHAEON as President of Asia Pacific. He previously started Skopus Medical in Singapore, a boutique medical device consulting firm where he provided strategic business planning and commercialization and distribution network services to companies looking to expand their commercial business into Asia Pacific. Prior to Skopus, Joshi served as Asia Pacific vice president for Bausch + Lomb’s full surgical franchise.

“I am excited to welcome Jeff and Kuntal to the ALPHAEON management team,” said Bob Rhatigan, ALPHAEON president and COO. “We are delighted to have such tenured and accomplished executives join our efforts as ALPHAEON expands its portfolio offering and broadens its footprint globally.”